Obigen Pharma Stock

Obigen Pharma ROCE

The Return on Capital Employed (ROCE) of Obigen Pharma (7876.TWO) as of Aug 11, 2026 is -17.18 %. In the previous year, Return on Capital Employed (ROCE) was -13.19 % — a change of 30.22% (lower).

ROCE

-17.18 %

YoY

30.22%

Last updated:

In 2026, Obigen Pharma's return on capital employed (ROCE) was -17.18 %, a 30.22% increase from the -13.19 % ROCE in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Obigen Pharma Stock analysis

What does Obigen Pharma do? Obigen Pharma is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Obigen Pharma's Return on Capital Employed (ROCE)

Obigen Pharma's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Obigen Pharma's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Obigen Pharma's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Obigen Pharma’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Obigen Pharma stock

Return on Capital Employed (ROCE) of Obigen Pharma is -17.18 % in 2026.

Return on Capital Employed (ROCE) of Obigen Pharma changed from -13.19 % to -17.18 %, representing a 30.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Obigen Pharma since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Obigen Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — Obigen Pharma

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Obigen Pharma